Epirubicin induces apoptosis in osteoblasts through death-receptor and mitochondrial pathways

• Published in: Apoptosis (London) Vol. 23; no. 3-4; pp. 226 - 236
• Main Authors: Huang, Tzu-Ching, Chiu, Pu-Rong, Chang, Wen-Tsan, Hsieh, Bau-Shan, Huang, Yu-Ci, Cheng, Hsiao-Ling, Huang, Li-Wen, Hu, Yu-Chen, Chang, Kee-Lung
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.04.2018; Springer; Springer Nature B.V
• Subjects: Anthracycline; Anthracyclines; Apoptosis; Bcl-2 protein; Biochemistry; Biocompatibility; Biomedical and Life Sciences; Biomedical materials; Biomedicine; Bone density; Bone loss; Bones; Cancer Research; Caspase; Caspase-3; Caspase-8; Caspase-9; Cell Biology; Cell differentiation; Cytochrome c; Density; Differentiation (biology); Epirubicin; FADD protein; FasL protein; Hematopoietic stem cells; Maturation; Medical colleges; Mineralization; Mitochondria; Oncology; Original Paper; Osteoblasts; Reactive oxygen species; Side effects; Stem cells; Toxicity; Virology; Osteoblast; Epirubicin; Bone; Mineralization; Apoptosis
• ISSN: 1360-8185; 1573-675X
• DOI: 10.1007/s10495-018-1450-2

Epirubicin is an anthracycline and is widely used in tumor treatment, but has toxic and undesirable side effects on wide range of cells and hematopoietic stem cells (HSC). Osteoblasts play important roles in bone development and in supporting HSC differentiation and maturation. It remains unknown whether epirubicin-induced bone loss and hematological toxicity are associated with its effect on osteoblasts. In primary osteoblast cell cultures, epirubicin inhibited cell growth and decreased mineralization. Moreover, epirubicin arrested osteoblasts in the G2/M phase, and this arrest was followed by apoptosis in which both the extrinsic (death receptor-mediated) and intrinsic (mitochondrial-mediated) apoptotic pathways were evoked. The factors involved in the extrinsic apoptotic pathway were increased FasL and FADD as well as activated caspase-8. Those involved in the intrinsic apoptotic pathway were decreased Bcl-2; increased reactive oxygen species, Bax, cytochrome c ; and activated caspase-9 and caspase-3. These results demonstrate that epirubicin induced osteoblast apoptosis through the extrinsic and intrinsic apoptotic pathways, leading to the destruction of osteoblasts and consequent lessening of their functions in maintaining bone density and supporting hematopoietic stem cell differentiation and maturation.